WHO halts hydroxychloroquine trial over safety fears

LONDON – The World Health Organization said that it will temporarily drop hydroxychloroquine – the malaria drug U.S. President Trump said he is taking – from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.

In a news briefing on ...

from www.washingtontimes.com stories: Health https://ift.tt/3c1X8f5

Post a Comment

Previous Post Next Post